The addition of recombinant adeno-associated viral vector- (rAAV-) mediated delivery of CYP2J2, exogenous EETs, or a selective 14,15-EET epoxygenase known as CYP102 F87V resulted in a high proliferation of cancer cells in vivo and in vitro [75]. The gene discussed is CYP2J2; the disease is cancer.